1. Home
  2. AKTX vs APWC Comparison

AKTX vs APWC Comparison

Compare AKTX & APWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKTX
  • APWC
  • Stock Information
  • Founded
  • AKTX N/A
  • APWC 1996
  • Country
  • AKTX United States
  • APWC Taiwan
  • Employees
  • AKTX N/A
  • APWC N/A
  • Industry
  • AKTX Biotechnology: Pharmaceutical Preparations
  • APWC Telecommunications Equipment
  • Sector
  • AKTX Health Care
  • APWC Industrials
  • Exchange
  • AKTX Nasdaq
  • APWC Nasdaq
  • Market Cap
  • AKTX 35.7M
  • APWC 34.6M
  • IPO Year
  • AKTX N/A
  • APWC 1997
  • Fundamental
  • Price
  • AKTX $1.12
  • APWC $1.85
  • Analyst Decision
  • AKTX Strong Buy
  • APWC
  • Analyst Count
  • AKTX 1
  • APWC 0
  • Target Price
  • AKTX $5.00
  • APWC N/A
  • AVG Volume (30 Days)
  • AKTX 20.9K
  • APWC 6.1K
  • Earning Date
  • AKTX 08-18-2025
  • APWC 08-25-2025
  • Dividend Yield
  • AKTX N/A
  • APWC N/A
  • EPS Growth
  • AKTX N/A
  • APWC N/A
  • EPS
  • AKTX N/A
  • APWC 0.17
  • Revenue
  • AKTX N/A
  • APWC $472,672,000.00
  • Revenue This Year
  • AKTX N/A
  • APWC N/A
  • Revenue Next Year
  • AKTX N/A
  • APWC N/A
  • P/E Ratio
  • AKTX N/A
  • APWC $10.92
  • Revenue Growth
  • AKTX N/A
  • APWC 11.02
  • 52 Week Low
  • AKTX $0.85
  • APWC $1.36
  • 52 Week High
  • AKTX $4.40
  • APWC $2.02
  • Technical
  • Relative Strength Index (RSI)
  • AKTX 44.73
  • APWC 68.07
  • Support Level
  • AKTX $1.08
  • APWC $1.76
  • Resistance Level
  • AKTX $1.15
  • APWC $1.93
  • Average True Range (ATR)
  • AKTX 0.03
  • APWC 0.05
  • MACD
  • AKTX 0.00
  • APWC 0.02
  • Stochastic Oscillator
  • AKTX 57.14
  • APWC 77.35

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)

Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in the manufacture and distribution of enameled wire, power cable, and telecommunications products in Thailand, Singapore, Australia, PRC, Hong Kong and certain other markets in the Asia Pacific region. It also provides project engineering services in the supply, delivery and installation of power cables (SDI). Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.

Share on Social Networks: